esv3825681
- Organism: Homo sapiens
- Study:estd219 (1000 Genomes Consortium Phase 3 Integrated SV)
- Variant Type:copy number variation
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:691,542
- Publication(s):1000 Genomes Consortium Phase 3 Integrated SV
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 1655 SVs from 76 studies. See in: genome view
Overlapping variant regions from other studies: 1655 SVs from 76 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
esv3825681 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000002.12 | Chr2 | 115,969,874 (-33, +33) | 116,661,415 (-33, +33) |
esv3825681 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000002.11 | Chr2 | 116,727,450 (-33, +33) | 117,418,991 (-33, +33) |
Variant Call Information
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
essv17810569 | Remapped | Perfect | NC_000002.12:g.(11 5969841_115969907) _(116661382_116661 448)del | GRCh38.p12 | First Pass | NC_000002.12 | Chr2 | 115,969,874 (-33, +33) | 116,661,415 (-33, +33) |
essv17810569 | Submitted genomic | NC_000002.11:g.(11 6727417_116727483) _(117418958_117419 024)del | GRCh37 (hg19) | NC_000002.11 | Chr2 | 116,727,450 (-33, +33) | 117,418,991 (-33, +33) |